Brian Goff
Patrimonio netto: 6 M $ in data 31/05/2026
Patrimonio netto: 6 M $ in data 31/05/2026
Brian M. Goff è nel consiglio di Pathways to College Network e Chief Commercial, Global Operations Officer & EVP presso Alexion Pharmaceuticals, Inc. Goff ha precedentemente ricoperto la posizione di Chief Operating Officer & Director presso Neurovance, Inc., Head-Global Hemophilia Franchise presso Baxter Healthcare Corp., Executive Vice President & President-Hematology presso Baxalta, Inc. e VP, Head-Primary Care & Established medicines presso Novartis Pharmaceuticals Corp. Goff ha conseguito una laurea presso lo Skidmore College e un MBA presso la Wharton School dell'Università della Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/06/2026 | 184.508 ( 0,31% ) | 5 M $ | 31/05/2026 | |
| 09/06/2026 | 32.609 ( 0,02% ) | 458 809 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Amministratore Delegato | 08/08/2022 |
| INTELLIA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 13/06/2024 |
Pathways to College Network | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Direttore operativo | 21/07/2021 |
| BAXALTA INC | Corporate Officer/Principal | 01/07/2016 |
| IDENIX PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 15/05/2012 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | - |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Commercial Services |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Skidmore College
Skidmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Pathways to College Network | |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale